Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma

View through CrossRef
Aim Although the ERBB proteins have been shown to be associated in many types of human tumours and serve as important cancer therapeutic targets, however, data regarding the expression and clinical relevance of ERBBs in nasopharyngeal carcinoma (NPC) are still conflicting. The aim of this study is to investigate the expression pattern of all ERBB members simultaneously in NPC tissues using immunohistochemistry and determine their clinical relevance. Methods The expression of all members of ERBB proteins was evaluated using immunohistochemistry on 82 NPC tissue samples. Relationship between the ERBB protein expression, clinicopathological parameters and patient outcome was assessed using univariate and multivariate analyses. Results We found that ERBB1, ERBB2 and ERBB3 were strongly expressed in the normal nasopharyngeal epithelial cells. A marked reduction of ERBB1 and ERBB2 expression in NPC was observed compared with the non-cancerous tissues. 76 of 82 (92.7%) cases were ERBB3-positive, while ERBB4 was not expressed in both normal and NPC. The univariate log-rank analysis showed that regional lymph node metastasis, systemic metastasis, recurrence and ERBB3 expression were associated with patient survival. The ERBB3 expression was not correlated to other clinicopathological factors. Furthermore, multivariate analysis revealed that ERBB3 expression was an independent prognostic factor influencing patient survival. Conclusions Our results suggested that the expression of ERBB3 is associated with patient survival and could serve as a novel and valuable predictor for prognostic evaluation of patients with NPC.
Title: ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma
Description:
Aim Although the ERBB proteins have been shown to be associated in many types of human tumours and serve as important cancer therapeutic targets, however, data regarding the expression and clinical relevance of ERBBs in nasopharyngeal carcinoma (NPC) are still conflicting.
The aim of this study is to investigate the expression pattern of all ERBB members simultaneously in NPC tissues using immunohistochemistry and determine their clinical relevance.
Methods The expression of all members of ERBB proteins was evaluated using immunohistochemistry on 82 NPC tissue samples.
Relationship between the ERBB protein expression, clinicopathological parameters and patient outcome was assessed using univariate and multivariate analyses.
Results We found that ERBB1, ERBB2 and ERBB3 were strongly expressed in the normal nasopharyngeal epithelial cells.
A marked reduction of ERBB1 and ERBB2 expression in NPC was observed compared with the non-cancerous tissues.
76 of 82 (92.
7%) cases were ERBB3-positive, while ERBB4 was not expressed in both normal and NPC.
The univariate log-rank analysis showed that regional lymph node metastasis, systemic metastasis, recurrence and ERBB3 expression were associated with patient survival.
The ERBB3 expression was not correlated to other clinicopathological factors.
Furthermore, multivariate analysis revealed that ERBB3 expression was an independent prognostic factor influencing patient survival.
Conclusions Our results suggested that the expression of ERBB3 is associated with patient survival and could serve as a novel and valuable predictor for prognostic evaluation of patients with NPC.

Related Results

Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Abstract 828: Screen for actionable ERBB3 mutations
Abstract 828: Screen for actionable ERBB3 mutations
Abstract Activating mutations and copy number variations in ERBB genes have been shown to serve as oncogenic driver mutations and predictive biomarkers for ERBB inhi...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Abstract 1593: Stat3 signaling in erbB3-mediated epithelial-mesenchymal transition in erbB2-positive breast cancer cells
Abstract 1593: Stat3 signaling in erbB3-mediated epithelial-mesenchymal transition in erbB2-positive breast cancer cells
Abstract Introduction: Understanding the mechanism of metastatic program is essential to reducing the mortality of cancer patients. It is well known that epithelial-...
A meta-analysis of prognosis difference between adolescent and adult nasopharyngeal carcinoma
A meta-analysis of prognosis difference between adolescent and adult nasopharyngeal carcinoma
Review question / Objective: Clinical trials for young patients with nasopharyngeal carcinoma are very limited. because of the rarity of nasopharyngeal carcinoma in young patients,...
Trans-activating mutations of the pseudokinase ERBB3
Trans-activating mutations of the pseudokinase ERBB3
Abstract Genetic changes in the ERBB family of receptor tyrosine kinases serve as oncogenic driver events and predictive biomarkers for ERBB inhibitor drugs. ERBB3 is a pse...
Fine-Needle Aspiration Cytology and Salivary Gland Tumors: A Cross-Sectional Study
Fine-Needle Aspiration Cytology and Salivary Gland Tumors: A Cross-Sectional Study
Abstract Introduction Salivary gland neoplasms are relatively rare and diverse, requiring accurate preoperative diagnosis. Although the Milan System for Reporting Salivary Gland C...

Back to Top